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Trichomoniasis, which is caused by the protist, Trichomonas 
vaginalis, is one of the most common non-viral sexually trans-
mitted infections, with an estimated prevalence of 276 million 
new infections worldwide each year [1,2]. T. vaginalis infection 
causes vaginitis and cervicitis, and is associated with serious 
complications, such as preterm birth, pelvic inflammatory dis-
ease, infertility, and an increased risk of co-infection with hu-
man immunodeficiency virus [3-9]. However, more than 50% 
of T. vaginalis infections in women are asymptomatic and re-
main undiagnosed [10]. Thus, early diagnosis and treatment 
of these infections, especially those that are asymptomatic, are 
imperative to alleviate this public health concern for women. 
The most common clinical diagnostic test for T. vaginalis in-
fection is microscopic examination of vaginal wet preparations 
(or “wet mount”); however, the sensitivity of wet mounts for 
detecting T. vaginalis is only 50-70% [11]. Recently, nucleic acid 
amplification tests, such as PCR and transcription-mediated 
amplification, using samples derived from vaginal swabs, have 
been developed. These methods show an improved sensitivity 
and specificity for the detection of T. vaginalis, compared to 
microscopic examination and culture, with sensitivity ranging 
from 64% to 100% [12,13]. 
Loop-mediated isothermal amplification (LAMP), which is 
a relatively straightforward and sensitive technique based on 
rapid DNA amplification under isothermal conditions, was re-
cently developed to remove the need for sophisticated and ex-
pensive thermal cyclers [14]. LAMP involves the specific am-
plification of target DNA by a Bacillus stearothermophilus (Bst) 
DNA polymerase, which has a high strand displacement DNA 
synthesis activity. The assay is performed with a set of 4-6 
primers that recognize independent regions of the target gene; 
this improves the specificity and the speed of the amplifica-
tion. Herein loop-structured amplicons are formed, which re-
sults in a typical ladder-pattern of multiple bands imaged after 
DNA electrophoresis [15]. A positive reaction is easily deter-
mined by eye as turbidity [16] or fluorescence through the in-
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Abstract: Trichomoniasis caused by Trichomonas vaginalis is a common sexually transmitted disease. Its association 
with several health problems, including preterm birth, pelvic inflammatory disease, cervical cancer, and transmission of 
human immunodeficiency virus, emphasizes the importance of improved access to early and accurate detection of T. 
vaginalis. In this study, a rapid and efficient loop-mediated isothermal amplification-based method for the detection of T. 
vaginalis was developed and validated, using vaginal swab specimens from subjects suspected to have trichomoniasis. 
The LAMP assay targeting the actin gene was highly sensitive with detection limits of 1 trichomonad and 1 pg of T. vagi-
nalis DNA per reaction, and specifically amplified the target gene only from T. vaginalis. Validation of this assay showed 
that it had the highest sensitivity and better agreement with PCR (used as the gold standard) compared to microscopy 
and multiplex PCR. This study showed that the LAMP assay, targeting the actin gene, could be used to diagnose early in-
fections of T. vaginalis. Thus, we have provided an alternative molecular diagnostic tool and a point-of-care test that may 
help to prevent trichomoniasis transmission and associated complications.
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clusion of fluorescent detection dyes, such as SYBR green or 
hydroxynaphthol, which can be detected using UV light 
[17,18]. These features allow the use of LAMP assays to detect 
many pathogenic organisms such as viruses, bacteria, fungi, 
and parasites [19-22]. 
The present study was undertaken to develop a LAMP assay 
detecting T. vaginalis and to validate the assay using vaginal 
swab samples obtained from females visiting the obstetrics 
and gynecology clinic with suspected T. vaginalis infections.
First, to select a target gene for the Trichomonas LAMP assay 
with high sensitivity and specificity, LAMP primers were de-
signed specific to several candidate genes, such as Tvk [23-25], 
β-tubulin [26,27], and actin [28,29]; all of which were previ-
ously reported as PCR markers for the detection of T. vaginalis. 
Sequences were retrieved from GenBank (Tvk, GenBank no. 
XM_001579000; β-tubulin, GenBank no. L05468; actin gene, 
GenBank no. AF237734), and LAMP primers were designed 
based on previously described methods using the Primer Ex-
plorer program [30] (http://primerexplorer.jp/elamp4.0.0/in-
dex.html). LAMP primer sets for T. vaginalis consisted of F3 
(forward outer primer), B3 (backward outer primer), FIP (for-
ward inner primer), BIP (backward inner primer), LF (loop 
forward primer), and LB (loop backward primer) (Table 1). 
LAMP was performed in a Loopamp real-time turbidimeter 
(Realoop-30; Eiken Chemical Co., Ltd., Tokyo, Japan) for 90 
min at 64˚C in a 25 μl mixture containing 40 pmol each of FIP 
and BIP, 5 pmol each of F3 and B3, 20 pmol each of LF and 
LB, 1.4 mM deoxynucleoside triphosphates, 0.8 M betaine, 1 
μl of Bst DNA polymerase (New England Biolabs, Ipswich, 
Massachusetts, USA) with 2.5 μl of buffer (20 mM Tris–HCl, 
pH 8.8; 10 mM KCl; 10 mM (NH4)2SO4; 8 mM MgSO4; and 
0.1% Tween 20), and 1 μl of template DNA. In our experi-
ments, the actin gene was the only target amplified among the 
3 candidate genes (data not shown) and was selected for fur-
ther experiments. An optimal temperature and time for the 
LAMP reaction was determined using a cloned actin gene frag-
ment (100 pg per reaction) under isothermal conditions at 
temperatures ranging from 60˚C to 65˚C for 120 min, by 
monitoring turbidity. Although amplification targeting of the 
actin gene was detected at all tested temperatures, a threshold 
value of absorbance (0.1) was reached fastest at 64°C (data 
not shown). Nonspecific amplification was not detected in the 
negative control (plasmid containing no insert) after at least 
120 min of incubation. Thus, the subsequent LAMP reactions 
were conducted at 64˚C for 90 min. 
To assess sensitivity, actin LAMP was conducted with serially 
diluted T. vaginalis genomic DNA ranging from 100 pg to 10 fg 
per reaction. This actin LAMP amplified the targeted region at 
each dilution from the highest concentration (1 ng per reac-
tion) (Fig. 1A-C) to as little as 1 pg of T. vaginalis genomic 
DNA per reaction; all concentrations tested reached the thresh-
old value of absorbance (0.1) within 40 min (Fig. 1A). As 
shown in Fig. 1B, a typical ladder pattern of amplified LAMP 
products was observed by agarose gel (2.0%) electrophoresis 
in lanes containing reactions performed with 1 pg to 1 ng of 
template DNA (Fig. 1B, lanes 1-4). To determine the specificity 
of the actin LAMP assay, the amplified LAMP products from 
the T. vaginalis genomic DNA were digested with HindIII. The 
sequence of the target region of actin contained this restriction 
site, and the expected fragments were generated (Fig. 1B, lane 
5). Amplified products of the positive reactions were also visu-
ally detectable using the Loopamp fluorescent detection re-
agent (FD; Eiken Chemical Co., Tokyo, Japan) under UV light 
(Fig. 1C). Alternatively, DNA was extracted from approximate-
ly 1×102 parasites, serially diluted 10-fold to the equivalent of 
100 to 0.01 parasites per reaction, and used as a template for 
the LAMP assays and PCR. The LAMP procedure amplified the 
DNA of parasites diluted to a concentration equivalent to 1 
parasite per reaction (Fig. 1D). Similarly, PCR amplified the 
DNA of parasites at the equivalent dilution (Fig. 1E). Thus, the 
detection limit of the LAMP assay was consistent with that of 
PCR. The specificity of the T. vaginalis LAMP assay was evaluat-
ed with the genomic DNA of 3 known sexually transmitted 
disease-associated species (Candida albicans, Chlamydia tracho-
matis, and Neisseria gonorrhoeae) and 3 pathogenic but tricho-
moniasis-unrelated protozoan parasites (Cryptosporidium par-
vum, Entamoeba histolytica, and Giardia lamblia) and 1 unrelat-
ed bacterial species (Escherichia coli). As shown in Fig. 1F, color 
change (green) of the amplified LAMP products, with the Loo-
pamp fluorescent detection reagent, was only observed for T. 
vaginalis genomic DNA. The T. vaginalis LAMP assay showed 
no detectable amplification of the other DNAs (brown). 
Table 1. Primer sequences for T. vaginalis actin LAMP  
Primer Sequence (5ʹ→3ʹ)
F3 GCTTCTCACAGAGCGTGG
B3 GCTCATTGCCGATTGTGATG
FIP AGGGCGACATAGCAAAGCTTCTGCTTTCAACACAACAGCCG
BIP TGCTGAAATGGAGAAGGCCGCCGTTGCCATCTGGAAGTGTG
LF CTTGATGTCACGAACGATTTCCTTT
LB TACAGACTCCTCCATCAACGT
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Fig. 1. Functionality of T. vaginalis actin LAMP assays. (A) LAMP on 10-fold serial dilutions of T. vaginalis genomic DNA (10 ng to 1 pg 
per reaction) monitored by measuring absorbance. Distilled water was used as a negative control. (B) LAMP products were visualized by 
gel electrophoresis. Lane 1, 1 ng; lane 2, 100 pg; lane 3, 10 pg; lane 4, 1 pg of T. vaginalis genomic DNA; lane 5, LAMP product after 
HindIII digestion; lane 6, distilled water; lane M, 100-bp DNA marker. (C) LAMP products were visualized under UV light using the Loo-
pamp fluorescent detection reagent. Lane 1, 1 ng; lane 2, 100 pg; lane 3, 10 pg; lane 4, 1 pg; lane 5, 100 fg; lane 6, 10 fg of T. vaginalis 
genomic DNA; lane 7, distilled water. (D-E) T. vaginalis at a density of 1×102 parasites/μl was serially diluted and tested using the LAMP 
assay (D) and PCR (E) with F3 and B3 primers (Table 1). Lane M, 100-bp DNA marker; lane 1, 100; lane 2, 10; lane 3, 1; lane 4, 0.1; 
lane 5, 0.01 parasite(s) per reaction; lane 6, positive control, 100 pg of plasmid DNA containing the LAMP targeting regions of actin 
gene; lane 7, distilled water. (F) Specificity of LAMP primers for detection of T. vaginalis assessed using template DNA from other micro-
bial species. Lane 1, T. vaginalis; lane 2, Candida albicans; lane 3, Chlamydia trachomatis; lane 4, Neisseria gonorrhoeae; lane 5, Cryp-
tosporidium parvum; lane 6, Entamoeba histolytica; lane 7, Giardia lamblia; lane 8, Escherichia coli; lane 9, human genomic DNA. LAMP 
products were visualized by a color change that was also observable by the naked eye under normal visible light. 
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To validate the T. vaginalis LAMP, vaginal swab specimens 
were obtained from 50 female patients, with clinical suspicion 
of trichomoniasis, visiting obstetrics and gynecology clinics. 
These samples were subjected to the LAMP assay and 3 alter-
native available methods of T. vaginalis detection, including 
microscopic examinations, PCR, and multiplex PCR. The 
study was approved by the Institutional Review Board of 
Kyungpook National University Hospital (IRB no. KNUH 
2013-04-051). Wet mount microscopy was performed at the 
clinic and classified as positive when motile trichomonads 
were observed. Genomic DNA was extracted from vaginal 
swab specimens using a QIAamp DNA mini kit (Qiagen, 
Hilden, Germany) and the diagnosis of T. vaginalis infection 
was made using the results of multiplex PCR and PCR that tar-
geted Tvk [27] in triplicate, as previously described [31]. In this 
study, PCR was used as a gold standard and the sensitivity, 
specificity, positive predictive value (PPV), and negative predic-
tive value (NPV) were calculated for each test (Table 2). The 
percentage sensitivities and specificities with 95% confidence 
intervals, differences in the sensitivities and specificities, and 
the degree of agreement were determined a previously de-
scribed [31]. Of the 50 female patients, 12 (24%), 23 (46%), 
40 (80%), and 43 (86%) were determined to be T. vaginalis 
positive using microscopy, multiplex PCR, PCR, and LAMP, re-
spectively. All 40 positive specimens identified by PCR were 
positive using the LAMP assay. When PCR was used as the 
gold standard, the LAMP assay had the highest diagnostic sen-
sitivity (P<0.001) and better agreement (kappa value: 0.789) 
with PCR than multiplex PCR and microscopy (Table 2). 
These findings indicate that the LAMP assay had a higher sen-
sitivity for detection of samples infected with T. vaginalis com-
pared to that of multiplex PCR and microscopic examination 
of wet mounts.
In this study, the LAMP assay was developed to detect T. vag-
inalis and was compared to currently available tests, including 
microscopic examinations, multiplex PCR, and PCR, using 50 
vaginal swab specimens. Being a diagnostic test for trichomo-
niasis, microscopic examinations of vaginal swab samples are 
still routinely performed in primary clinics of South Korea. As 
shown in Table 2, microscopic examinations had the lowest 
sensitivity (30.0%) among the 4 tests performed in this study. 
This result is noteworthy since misdiagnosis of T. vaginalis, re-
sulting from use of a less accurate diagnostic method, would 
result in a persistent infectious state, and may subsequently 
lead to serious T. vaginalis-associated complications and possi-
ble transmission of the infection. Among the currently avail-
able tests, PCR is still the most sensitive and specific method 
for T. vaginalis detection. However, the need for expensive lab-
oratory equipment, trained specialists, and time-consuming 
procedures limit the usefulness of PCR in the primary clinic. 
In contrast, a LAMP assay does not require a thermal cycler 
and can be performed with minimal laboratory facilities, such 
as a heat block or a water bath, and yields results that can be 
assessed by eye. The straightforward sample preparation for 
molecular diagnosis reduces the risk of cross-contamination 
and the turnaround time for diagnosis, therefore, we prepared 
the crude cell lysates from vaginal swab specimens by direct 
heat-treatment [32]. 
LAMP assays and PCR performed on heat-treated lysates 
yielded the same results as those obtained using DNA extract-
ed using a DNeasy tissue kit (data not shown). A T. vaginalis 
LAMP assay, based on 2-kb repeated DNA species-specific se-
quence has recently been developed [33] and evaluated for its 
sensitivity and specificity using spiked genital swabs and urine 
specimens. However, the goal of the present study was to select 
more efficient target DNA, through comparison of DNA am-
plification of candidate genes, and validate the assay using 
clinically obtained specimens. Moreover, the results of the ac-
tin LAMP assay using heat-treated samples were consistent 
with those of the LAMP assay using samples obtained from a 
commercial kit. Thus, this T. vaginalis LAMP assay could elimi-
nate the need for DNA extraction, without compromising as-
Table 2. Comparison of diagnostic methods among T. vaginalis detection (n=50)      
Assay No. positive Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI) Kappa
Microscopy 12 30 (17.1-46.7) 100 (65.5-100) 100 (69.9-100) 26.3 (13.9-43.4) 0.146 (0.037-0.256)
Multiplex PCR 23 57.5 (41.0-72.6) 100 (65.5-100) 100 (82.2-100) 37 (20.1-63.2) 0.351 (0.161-0.542)
PCR 40
LAMP 43 100 (89.1-100) 70 (35.4-91.9) 93 (79.9-98.2) 100 (56.1-100) 0.789 (0.562-1)
Sensitivity and specificity of the tests were determined using the PCR results as gold standard.      
PPV, positive predictive value; NPV, negative predictive value; CI, confidence interval.      
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say sensitivity, and reduce the time required to diagnose. Fur-
thermore, individuals with low parasite density can provide 
reservoirs for transmission, and thus an early and accurate di-
agnostic tool such as the one described herein could help to 
prevent transmission of T. vaginalis infections. 
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